An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi

BACKGROUND: Recently, a 23‐gene signature was developed to produce a melanoma diagnostic score capable of differentiating malignant and benign melanocytic lesions. The primary objective of this study was to independently assess the ability of the gene signature to differentiate melanoma from benign...

Descripción completa

Detalles Bibliográficos
Autores principales: Clarke, Loren E., Flake, Darl D., Busam, Klaus, Cockerell, Clay, Helm, Klaus, McNiff, Jennifer, Reed, Jon, Tschen, Jaime, Kim, Jinah, Barnhill, Raymond, Elenitsas, Rosalie, Prieto, Victor G., Nelson, Jonathan, Kimbrell, Hillary, Kolquist, Kathryn A., Brown, Krystal L., Warf, M. Bryan, Roa, Benjamin B., Wenstrup, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324582/
https://www.ncbi.nlm.nih.gov/pubmed/27768230
http://dx.doi.org/10.1002/cncr.30385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324582/
https://www.ncbi.nlm.nih.gov/pubmed/27768230
http://dx.doi.org/10.1002/cncr.30385

Ejemplares similares